Tag: Vivos
Vivos Therapeutics, cardiovascular group partner to offer coordinated model for sleep therapy
August 31, 2026HME News Staff
LITTLETON, Colo. – Vivos Therapeutics, medical device and health care services company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from obstructive sleep apnea (OSA) and other health conditions, has executed definitive collaboration and operating agreements with South Palm Cardiovascular Associates (SPCVA) to support establishing and operating a regional Sleep & Airway Medicine Center (SAMC) in Palm Beach County, Fla. The agreements...
In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks
April 18, 2025HME News Staff
DENVER – Revelstoke Capital Partners, a health care-focused private equity firm, has completed a recapitalization of AOM Infusion, a specialty infusion provider of chronic therapy management.
AOM Infusion provides patients with intravenous immunoglobulin, biologics and other therapies, addressing more than 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The company also provides support services, including skilled infusion...
Vivos to acquire sleep center
April 17, 2025HME News Staff
LITTLETON, Colo. - Vivos Therapeutics has signed a definitive agreement to acquire The Sleep Center of Nevada for up to $9 million.
The deal includes $6 million in cash, $1.5 million in Vivos common stock at closing, and potential additional $1.5 million in stock tied to performance milestones.
SCN, founded in 2008, is the largest sleep center in Nevada, with approximately 3,000 new patients each month. It operates seven locations with nearly 50 beds for overnight sleep testing.
“We...
FDA clears Vivos device for OSA
November 30, 2023HME News Staff
LITTLETON, Colo. – Vivos Therapeutics has received 510(k) clearance from the U.S. Food and Drug Administration for treating severe obstructive sleep apnea in adults using its removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances. CARE appliances include the flagship DNA oral appliance, the mRNA oral appliance and the mmRNA oral appliance. “This achievement is a pivotal milestone for Vivos and elevates our proven treatment options right into the mainstream of...
In brief: Vivos picks Lincare, industry wins in GA, Belluscura tries DTC
October 27, 2023HME News Staff
LITTLETON, Colo. – Vivos Therapeutics, a medical technology company that makes oral appliances for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, has signed a distribution agreement with Lincare.
The agreement follows a successful a distribution pilot with Lincare and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment companies in the United States. Lincare will have a six-month exclusive deal...
Vivos announces deal with Lincare
October 25, 2023HME News Staff
LITTLETON, Colo. – Vivos Therapeutics, a medical technology company that makes oral appliances for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, has signed a distribution agreement with Lincare.
The agreement follows a successful a distribution pilot with Lincare and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment companies in the United States. Lincare will have a six-month exclusive deal...
Vivos appliance gets clinical trial
October 12, 2023HME News Staff
LITTLETON, Colo. – Vivos Therapeutics, a medical technology company focused on developing treatments for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, announced that its flagship daytime-nighttime appliance (DNA) will be tested in a clinical trial at Stanford Medicine. “We are extremely excited to be starting this trial at Stanford Medicine, which has been in the works for some time” said R. Kirk Huntsman, chairman and CEO of Vivos. “I...
Vivos closes on funding
January 11, 2023HME News Staff
LITTLETON, Colo. – Vivos Therapeutics, Inc., a medical technology company focused on developing treatments for patients suffering from mild-to-moderate obstructive sleep apnea, has closed its previously announced private placement offering with a single institutional investor for $8 million in gross proceeds. After the placement agent fees and estimated offering expenses, the company expects to receive net proceeds of approximately $7.4 million, which it intends to use for general working capital...
Vivos receives clearance for appliance to treat OSA
January 9, 2023HME News Staff
LITTLETON, Colo. - Vivos Therapeutics, a medtech company focused on developing innovative treatments for patients suffering from obstructive sleep apnea, has received clearance from the U.S. Food and Drug Administration for its proprietary daytime-nighttime (DNA) appliance. With FDA clearance, the DNA appliance offers a new treatment regimen that opens the airway by expanding the palate and training the tongue to rest in the proper position, converting patients to nasal as opposed to oral breathing. ...
Vivos sees significant increase in HST
January 20, 2022HME News Staff
HIGHLANDS RANCH, Colo. – Vivos Therapeutics saw an 18-times increase in the total number of SleepImage Home Sleep Apnea Tests given across its network of trained dentists (known as Vivos Integrated Practices or VIPs) for the three months ended Dec. 31, 2021. The company also reported a 5.7-times increase in the number of VIPs administering HSTs; and a 3-times increase in the average number of HSTs being administered per VIP. “We have always believed that the pathway to getting more patients...